Ingalls & Snyder LLC has filed its 13F form on July 31, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.82 Billion distributed in 466 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $567M, Microsoft Corp with a value of $102M, Williams Companies, Inc. with a value of $89.1M, Berkshire Hathaway Inc Class B with a value of $86M, and Exxon Mobil Corp with a value of $83.8M.

Examining the 13F form we can see an decrease of $222M in the current position value, from $3.04B to 2.82B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.82 Billion
Healthcare: $769 Million
Technology: $352 Million
Energy: $348 Million
Financial Services: $347 Million
Industrials: $215 Million
Communication Services: $185 Million
Consumer Cyclical: $170 Million
Consumer Defensive: $115 Million
Other: $252 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 466
  • Current Value $2.82 Billion
  • Prior Value $3.04 Billion
  • Filing
  • Period Q2 2025
  • Filing Date July 31, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 33 stocks
  • Additional Purchases 102 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 197 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.